US FTC pledges action against exclusionary prescription drug rebates that foreclose competition
The US Federal Trade Commission today vowed to take action against exclusionary rebates paid to prescription drug middlemen that hurt competition and keep lower-cost, life-saving drugs out of reach for patients.The...To view the full article, register now.
Already a subscriber? Click here to view full article